- Home
- ITIC vs FTRE Comparison
ITIC vs FTRE Comparison
Compare ITIC & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITIC
- FTRE
- Stock Information
- Founded
- ITIC 1972
- FTRE 1996
- Country
- ITIC United States
- FTRE United States
- Employees
- ITIC N/A
- FTRE N/A
- Industry
- ITIC Specialty Insurers
- FTRE Medical Specialities
- Sector
- ITIC Finance
- FTRE Health Care
- Exchange
- ITIC Nasdaq
- FTRE Nasdaq
- Market Cap
- ITIC 440.1M
- FTRE 469.0M
- IPO Year
- ITIC N/A
- FTRE N/A
- Fundamental
- Price
- ITIC $195.87
- FTRE $5.28
- Analyst Decision
- ITIC
- FTRE Hold
- Analyst Count
- ITIC 0
- FTRE 11
- Target Price
- ITIC N/A
- FTRE $17.10
- AVG Volume (30 Days)
- ITIC 90.6K
- FTRE 3.7M
- Earning Date
- ITIC 08-05-2025
- FTRE 05-12-2025
- Dividend Yield
- ITIC 0.94%
- FTRE N/A
- EPS Growth
- ITIC 18.56
- FTRE N/A
- EPS
- ITIC 15.69
- FTRE N/A
- Revenue
- ITIC $261,197,999.00
- FTRE $2,685,600,000.00
- Revenue This Year
- ITIC N/A
- FTRE N/A
- Revenue Next Year
- ITIC N/A
- FTRE $1.33
- P/E Ratio
- ITIC $12.37
- FTRE N/A
- Revenue Growth
- ITIC 15.27
- FTRE N/A
- 52 Week Low
- ITIC $168.74
- FTRE $3.97
- 52 Week High
- ITIC $290.40
- FTRE $28.41
- Technical
- Relative Strength Index (RSI)
- ITIC 29.02
- FTRE 53.54
- Support Level
- ITIC $190.20
- FTRE $3.97
- Resistance Level
- ITIC $235.99
- FTRE $4.46
- Average True Range (ATR)
- ITIC 8.84
- FTRE 0.37
- MACD
- ITIC -5.20
- FTRE 0.20
- Stochastic Oscillator
- ITIC 9.11
- FTRE 78.92
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.